BCTG (BCTG) Shareholders Approve Tango Deal

BCTG Acquisition Corporation  (NASDAQ:BCTG) announced in a press release today that shareholders approved its combination with biotech firm Tango Therapeutics in a meeting held yesterday. Approximately $11 million of shares were redeemed in connection with the vote leaving Tango a total cash position of approximately $515 million following transactions costs. This includes approximately $156 million
Read More